Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03209102 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Emotional Regulation and Impulsivity Among Adolescents with Borderline Personality Disorder

Study acronym: ADOLIMIS
StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date changed from estimate of Oct 2021 to Oct 4, 2024
    • Study completion date: Oct 2021 to Jan 3, 2026
    v3
  2. Primary completion date: Sep 2019 to Oct 2021
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Study completion date: Sep 2020 to Oct 2021
    • Start date changed from estimate of Jul 2017 to Oct 4, 2017
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to better understand the behavioral, neurobiological and hormonal underpinnings of stress and reward reactivity of adolescents suffering from borderline personality disorder compared to healthy adolescents by a multimodal approach based on clinical assessments, structural and functional mri and experimental acute stress exposure.
Trial Details
NCT Number NCT03209102
Lead Sponsor Institut National de la Santé Et de la Recherche Médicale, France
Conditions
(from sponsor)		 Borderline Personality Disorder, Adolescent Development
Related terms Borderline Personality Disorder
Enrollment 66 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov